{"title":"A Brief Overview of Neonatal Abstinence Syndrome.","authors":"Barbara R McClaskey","doi":"10.1891/NN-2024-0057","DOIUrl":"10.1891/NN-2024-0057","url":null,"abstract":"<p><p>This article provides a brief overview of the incidence, pathophysiology, diagnosis, and management of neonatal abstinence syndrome. Areas of discussion include genetics, pathophysiology, diagnostic tools, and pharmacologic and nonpharmacologic management of neonatal abstinence syndrome.</p>","PeriodicalId":46706,"journal":{"name":"Neonatal Network","volume":"44 4","pages":"243-247"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neonatal NetworkPub Date : 2025-08-01DOI: 10.1891/0730-0832.44.4.285
{"title":"Nursing Continuing Professional Development Activities: July/August 2025.","authors":"","doi":"10.1891/0730-0832.44.4.285","DOIUrl":"https://doi.org/10.1891/0730-0832.44.4.285","url":null,"abstract":"","PeriodicalId":46706,"journal":{"name":"Neonatal Network","volume":"44 4","pages":"285-286"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Impact of Health Care Access and Quality of Care on Neonates and Their Families.","authors":"Lenora Marcellus, Miranda May Marie Amundsen","doi":"10.1891/NN-2025-0017","DOIUrl":"10.1891/NN-2025-0017","url":null,"abstract":"<p><p>Access to and quality of health care is one of the five determinants of health that significantly influences the health and well-being of neonates and their families. This column considers the challenges birth parents and neonates may have in accessing care and whether the care they do access is safe and of high quality. As obstetric mortality rates continue to increase and neonatal mortality rates fail to decline in the United States, there is a critical need to consider how nurses can support families in obtaining the care they require. Advocating for access to health care and providing high-quality care that is free from discrimination is necessary to improving outcomes for families and supporting future engagement in the health care system. NICU nurses hold a pivotal role in fostering inclusive environments, providing high-quality care, and advocating for improved access.</p>","PeriodicalId":46706,"journal":{"name":"Neonatal Network","volume":"44 4","pages":"277-282"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Second-Line Medications for Neonatal Opioid Withdrawal Syndrome/Neonatal Abstinence Syndrome.","authors":"Susan Givens Bell","doi":"10.1891/NN-2024-0059","DOIUrl":"10.1891/NN-2024-0059","url":null,"abstract":"<p><p>Nonpharmacologic management is the first-line therapy for infants experiencing neonatal opioid withdrawal syndrome (NOWS) and/or neonatal abstinence syndrome (NAS). Currently, the most prescribed first-line pharmacologic agent is an opioid, most often morphine, but methadone and buprenorphine are preferred by some providers. For some infants, an opioid, along with maximized nonpharmacologic strategies, does not provide adequate symptom relief and a second-line agent is needed. Phenobarbital and clonidine are two commonly prescribed second-line agents for the management of NOWS/NAS. This column will describe these two commonly prescribed second-line agents.</p>","PeriodicalId":46706,"journal":{"name":"Neonatal Network","volume":"44 4","pages":"271-276"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Best Prescription for Caring for a NAS or NOWS Family.","authors":"Deborah Discenza","doi":"10.1891/NN-2025-0018","DOIUrl":"10.1891/NN-2025-0018","url":null,"abstract":"<p><p>As a parent in the NICU, we families have an automatic friendship that simply requires the phrase \"NICU Baby\" for a club none of us expected to join. Along with premature infants, infants with heart conditions, rare diseases, and more, there is one embattled group: the neonatal abstinence syndrome or neonatal opioid withdrawal syndrome infants. So many assumptions swirl around these infants and automatic accusations at the birthing parent. But what if we had a different way, a different prescription in helping this fragile family thrive? It is possible and it is needed.</p>","PeriodicalId":46706,"journal":{"name":"Neonatal Network","volume":"44 4","pages":"283-284"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zak Webber, Lisa M Grisham, Omar Z Meziab, Andrew W Hoyer, Brent J Barber, Angelina M Price, Scott E Klewer, Tally M Largent-Milnes, Michael D Seckeler
{"title":"Higher Incidence of Moderate and Severe Congenital Heart Disease in Patients With Neonatal Abstinence Syndrome.","authors":"Zak Webber, Lisa M Grisham, Omar Z Meziab, Andrew W Hoyer, Brent J Barber, Angelina M Price, Scott E Klewer, Tally M Largent-Milnes, Michael D Seckeler","doi":"10.1891/NN-2024-0036","DOIUrl":"10.1891/NN-2024-0036","url":null,"abstract":"<p><p>Studies suggest that in utero opioid exposure may be associated with congenital heart disease (CHD). We sought to assess the incidence of CHD in infants with neonatal abstinence syndrome (NAS). A review of a national, administrative database from January 2019 to December 2022 was conducted for neonates with an <i>ICD-10</i> code for NAS and moderate or severe CHD. The incidence of CHD in NAS (the main outcome variable) was compared to those without NAS using χ<sup>2</sup> analysis and odds ratios for CHD with significant differences. There were 4,994,919 neonatal admissions during the study period: 26,284 with NAS (2.3% had CHD) and 4,968,715 without NAS (1.1% had CHD) (<i>p</i> < .001). Odds ratios for five CHD types (atrioventricular septal defect, aortic coarctation/hypoplastic arch, double-inlet left ventricle, pulmonary valve stenosis, and pulmonary artery stenosis) were higher in NAS. There is the suggestion of a higher incidence of some forms of moderate and severe CHD in neonates with NAS.</p>","PeriodicalId":46706,"journal":{"name":"Neonatal Network","volume":"44 4","pages":"256-260"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neonatal NetworkPub Date : 2025-06-01DOI: 10.1891/0730-0832.44.3.220
{"title":"Nursing Continuing Professional Development Activities: May/June 2025.","authors":"","doi":"10.1891/0730-0832.44.3.220","DOIUrl":"10.1891/0730-0832.44.3.220","url":null,"abstract":"","PeriodicalId":46706,"journal":{"name":"Neonatal Network","volume":"44 3","pages":"220-221"},"PeriodicalIF":0.6,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144334071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Ins and Outs of the Complete Blood Count With Differential: Back to Basics.","authors":"Colleen Reilly Moss, Michele Savin, Curry Bordelon, Leann Baker","doi":"10.1891/NN-2024-0072","DOIUrl":"10.1891/NN-2024-0072","url":null,"abstract":"<p><p>A complete blood count (CBC) with differential is an essential laboratory test used to evaluate overall physiologic health and detect potential disorders in neonates. This test provides valuable insights into various blood cell types and structures and offers information on infections, immune status, anemia, and other hematologic conditions. Given the unique physiology and susceptibility of neonates to infections and other complications, interpreting the CBC with differential results in this population requires a specialized approach. The purpose of this article is to describe the components of the CBC and provide the reader with a neonatal case study to analyze and calculate values from within the CBC. The article also highlights common disorders causing abnormal neonatal CBC values and potential outcomes.</p>","PeriodicalId":46706,"journal":{"name":"Neonatal Network","volume":"44 3","pages":"177-186"},"PeriodicalIF":0.6,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144334074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marianne Bracht, Fabiana Bacchini, Barry Rodgers-Gray, James O Edwards, Bosco A Paes
{"title":"Parental Knowledge and Understanding of Respiratory Syncytial Virus and How to Decrease the Risk of Infection: The Canadian Premature Babies Foundation Survey 2023.","authors":"Marianne Bracht, Fabiana Bacchini, Barry Rodgers-Gray, James O Edwards, Bosco A Paes","doi":"10.1891/NN-2024-0064","DOIUrl":"10.1891/NN-2024-0064","url":null,"abstract":"<p><p>The purpose of this survey is to evaluate parental knowledge of respiratory syncytial virus (RSV) and its prevention. The study design used is an online survey. A total of 331 Canadian parents of preterm infants completed the survey. The main outcome variables used in the survey are knowledge of RSV, sources of information, and understanding strategies to decrease the risk of RSV infection. Of the participants, 99.4% understood the seriousness of RSV, but 19.6% were not confident in their knowledge. Respiratory syncytial virus education was provided to 75.6% in the hospital. 98.7% of uninformed parents wished they had been enlightened. Postdischarge, 60.5% felt unconfident in protecting their infant, and 70.8% searched for information. Health care professionals were the recommended source for RSV information (82.4-85.0%). Despite 98.6% understanding the importance of childhood immunizations, 24.1% remained anxious. Moreover, 65.4% received information about palivizumab, and 97.0% were confident about its use. Although 79.4% were unaware of nirsevimab, 75.4% would accept it. For maternal RSV vaccination, acceptability was 72.6%. Parents require accurate, reliable, and consistent information on RSV and its prevention, delivered to them in the NICU, following discharge, and via reputable online resources. Health care professionals, both in the NICU and community, should be well-informed and receive regular education throughout the year on RSV and the latest thinking on prevention.</p>","PeriodicalId":46706,"journal":{"name":"Neonatal Network","volume":"44 3","pages":"187-196"},"PeriodicalIF":0.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144334072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}